期刊文献+

2型糖尿病患者血管性病变与血小板参数变化的观察 被引量:2

The relation between platelet indices and vascular lesion in patients with T_2DM
下载PDF
导出
摘要 目的探讨血小板参数测定对糖尿病血管病变的诊断价值。方法86例2型糖尿病(T2DM)患者作为观察组(T2DM组),另选46例健康体检者作为对照组。2组均为清晨空腹采集静脉血5ml,分别检测血小板总数(PLT)、血小板平均体积(MPV)、血小板压积(PCT)、血小板分布宽度(PDW)及分离血清检测葡萄糖(Glu)。结果T2DM组空腹血糖(FPG)为(11.9±6.9)mmol/L,显著高于对照组的(4.5±1.7)mmol/L(P<0.01);有血管病变组较无血管病变组FPG比较差异无统计学意义(P>0.05)。T2DM组与健康对照组比较,MPV、PDW明显增大(P<0.01),PLT计数降低(P<0.05);而2组间PCT检测值无明显差异(P>0.05)。有血管病变组较无血管病变组MPV和PDW明显增高(P<0.01),PLT计数低于无血管病变组(P<0.05),2组间PCT检测值无明显差异(P>0.05)。结论血常规中血小板参数检查对发现T2DM有无血管病变有一定的临床意义。 Objective To investigate the clinical value of the platelet indices in the spectrum of thrombocytopenia. Methods 86 patients with vascular lesion were in observation group, and 46 healthy persons were choosed as the control group. The level of PLT, MPV, PCT, PDW and Glu were detected and compared. Results The FPG in observation was ( 11.9 ± 6.9) mmol/L , much higher than (4.5± 1.7 ) mmol/L in control group ( P 〈 0.01 ), and there was obvious difference in MPV, PDW and PLT between the two groups( P 〈 0.01 or P 〈 0.05 ) except PCT( P 〉 0.05 ). The level of FPG was not different between vascular lesion group and non - vascular lesion group( P 〉 0.05 ), but MPV, PDW and PLT were obviously different ( P 〈 0.01 or P 〈 0.05 ). Conclusion The platelet indices could provide important clinical information about the underlying conditions and prognosis of vascular lesion in patients with T2DM.
作者 余宝珠
出处 《临床合理用药杂志》 2009年第8期24-25,共2页 Chinese Journal of Clinical Rational Drug Use
关键词 2型糖尿病 血管性病变 血小板参数 T2 DM Vascular lesion Platelet indices
  • 相关文献

参考文献1

  • 1Craig B T,Katherine A.Size dependent platelet subpopulation rela-tionship of platelet volume to ultrastructure enzymatic activity and function[].British Journal of Haematology.1982

同被引文献18

  • 1张海燕,曾敬,王正君,王静.糖肾健汤治疗早期Ⅱ型糖尿病肾病46例[J].陕西中医,2004,25(12):1082-1084. 被引量:6
  • 2李宁,林莺.黄芪注射液治疗早期糖尿病肾病疗效观察[J].陕西医学杂志,2004,33(12):1136-1137. 被引量:4
  • 3刘涛,陈美璞,何东华,刘兆荣,张学勇,叶继锋.糖尿病微血管病变与血小板参数的关系[J].临床荟萃,2005,20(11):610-611. 被引量:9
  • 4Osawa H, Ochi M, Kato K, et al. Serum resistin is associated with the severity of microangiopathies in type 2 diabetes. Biochem Biophys Res Commun, 2007,355(2) : 342-346.
  • 5Mu H, Ryuji Ohashi R, Yan S. Adipokine resistin promotes in vitro angiogenesis of human endothelial cells. Cardiovasc Res, 2006,70 (1): 146-157.
  • 6Axelsson J, Bergsten A, Qureshi AR, et al. Elevated resisfin levels in chronic kidney disease are associated with decreased glomerular filtration rate and inflammation, but not with insulin resistance. Kidney Int, 2006,69(3) :596-604.
  • 7Verma S, Li SH, Wang CH,et al. Resistin promotes endothelial cell activation : further evidence of adipokine-endothelial interaction. Circulation, 2003,108(6) : 736-740.
  • 8Yang WY, Lu JM, Weng JP. Prevalence of diabetes a- mong men and women in China. [J. Engl J Med,2010, 362:1090-1101.
  • 9Joya-Galeana J, Fernandez M, Cervera A, etal. Effects of insulin and oral anti-diabetic agents on glucose metabo- lism, vascular dysfunction and skeletal muscle inflamma- tion in type 2 diabetic subjects[J]. Diabetes Metab Res Rev, 2011, 27(4) :373-382.
  • 10张悦,刘巍,羡晓辉,陈海英,苏胜偶.2型糖尿病微血管病变患者纤溶系统变化与胰岛素抵抗的关系[J].临床荟萃,2008,23(6):397-399. 被引量:3

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部